| Category : |
API |
| CAS No. : |
1092939-17-7 |
| Synonyms : |
Ruxolitinib Phosphate; Ruxolitinib |
| Mol. Formula : |
C17H18N6·H3PO4 |
| Assay : |
98.0% to 102.0% on anhydrous basis |
| Specification : |
in-house |
| Certificates and Documents : |
GMP/FDA/DMF/WC |
| Appearance : |
White or almost white powder |
| Grade : |
Pharma Grade |
| Application : |
Ruxolitinib is used to treat mild to moderate atopic dermatitis (eczema) in non-immunocompromised patients whose condition is not well controlled with other topical treatments or when these treatments are not recommended. Ruxolitinib topical is also used to treat a skin disease called nonsegmental vitiligo. |
| Packaging Details : |
10Kg/Drum |
| Delivery time : |
1-2 weeks |
| Storage : |
Sealed, protect from light |
| Shelf life : |
3 years |
